A half-century of streptococcal research: Then & now

Indian Journal of Medical Research

Volumn 115, Issue JUNE, 2002, Pages 215-241

  Krause, Richard M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Acute rheumatic fever; GAS pharyngitis; Group A streptococcus; L forms; M protein

Indexed keywords

ANTIBIOTIC AGENT; ANTIBODY; BENZATHINE PENICILLIN; GROUP A TYPE 1 M PROTEIN VACCINE; M PROTEIN; PENICILLIN G; PROTEINASE; STREPTOCOCCUS VACCINE; STREPTOLYSIN O; STREPTOLYSIN S; SULFONAMIDE; TOXIN; UNCLASSIFIED DRUG;

ACUTE GLOMERULONEPHRITIS; ANTIGENICITY; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIOPHAGE; CELLULAR DISTRIBUTION; CLINICAL TRIAL; CLONE; DEVELOPING COUNTRY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG SYNTHESIS; EVOLUTION; GENE SEQUENCE; GENETIC CODE; GENETIC EPIDEMIOLOGY; HEMOLYTIC STREPTOCOCCUS; HUMAN; IMMUNITY; INCIDENCE; LYSOGENIZATION; NONHUMAN; PHAGOCYTOSIS; PHARYNGITIS; PHENOTYPE; POPULATION RESEARCH; PROTEIN PURIFICATION; RESEARCH; REVIEW; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SKIN INFECTION; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION;

ANIMALS; HISTORY, 20TH CENTURY; HUMANS; PENICILLINS; PHARYNGITIS; POLYSACCHARIDES, BACTERIAL; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 0036592226     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. Finland M. Use of penicillin in infections other than bacterial endocarditis. Adv Intern Med 1947; 2: 350-438.
2. Massell BF. Prevention of rheumatic fever with sulphonamides. Chap. 9, In: Rheumatic fever and streptococcal infection. Unraveling the mysteries of a dread disease. Boston: The Francis A. Countway Library of Medicine. Distributed by the Harvard University Press; 1997 p. 147-58.
3. Rubbo SD, Holmes MC, Stokes HL. Prophylactic sulphanilamide in rheumatic fever. Review of 548 cases. Lancet 1949; ii : 311-6.
4. Hodges RG. The use of sulphadiazine as a prophylactic against respiratory disease. N Engl J Med 1944; 231 : 817-20.
5. Hartman TL. Sulphonamide sensitivity determinations of haemolytic streptococci isolated from patients before and after treatment with sulphadiazine. Bull Johns Hopkins Hosp 1946; 79 : 342-8.
6. Massell BF. Prevention of rheumatic fever with penicillin. Chap. 10. In: Rheumatic fever and streptococcal infection. Unraveling the mysteries of a dread disease. Boston: The Francis A. Countway Library of Medicine. Distributed by the Harvard University Press; 1997 p. 159-82.
7. Denny FW, Wannamaker LW, Brink WR, Rammelkamp CH Jr, Custer EA. Prevention of rheumatic fever. Treatment of the preceding streptococcic infection. JAMA 1950; 143 : 151-3.
8. Stollerman GH, Rusoff JH. Prophylaxis against group A streptococcal infections in rheumatic fever patients. Use of a new repository penicillin preparation. JAMA 1952; 150 : 1571-5.
9. Stollerman GH, Russof JH, Hirschfeld I. Prophylaxis against group A streptococci in rheumatic fever. The use of a single monthly injection of benzathine penicillin G. N Engl J Med 1955; 252: 787-92.
10. Dochez AR, Avery OT, Lancefield RC. Studies on the biology of streptococcus. I. Antigenic relationships between strains of Streptococcus haemolyticus. J Exp Med 1919; 30 : 179-213.
11. McCarty M. Rebecca Craighill Lancefield 1895-1981. In: Biographical memoirs, vol. 57. Washington, D.C.: The National Academy Press; 1987 p. 227-46.
12. Lancefield RC. The antigenic complex of Streptococcus haemolyticus. II. Chemical and immunological properties of the protein fractions. J Exp Med 1928; 47 : 469-480.
13. Lancefield RC. The antigenic complex of Streptococcus haemolyticus. III. Chemical and immunological properties of the species-specific substance. J Exp Med 1928; 47 : 481-91.
14. Coburn AF. Factor of infection in the rheumatic state. Baltimore: Williams and Wilkins; 1931.
15. Collis WRF. Acute rheumatism and haemolytic streptococci. Lancet 1931; 1 : 1341-5.
16. Fowler JK. On the association of affections of the throat with acute rheumatism. Lancet 1880; ii : 933-4.
17. Lancefield RC. Specific relationship of cell composition to biological activity of haemolytic streptococci. Harvey Lect 1941; 36 : 251-90.
18. Massell BF. Confirmation of the haemolytic streptococcus hypothesis. Chap. 6. In: Rheumatic fever and streptococcal infection. Unraveling the mysteries of a dread disease. Boston: The Francis A. Countway Library of Medicine. Distributed by the Harvard University Press; 1997 p. 93-110.
19. Rothbard S. Bacteriostatic effect of human sera on group A streptococci. I. Type-specific antibodies in sera of patients convalescing from group A streptococcal pharyngitis. J Exp Med 1945; 82 : 93-106.
20. Watson RF, Rothbard S, Swift HF. Type-specific protection and immunity following intranasal inoculation of monkeys with group A haemolytic streptococci. J Exp Med 1946; 84 : 127-42.
21. Wannamaker LW. The epidemiology of streptococcal infections. In: McCarty M, editor. Streptococcal infections. New York: Columbia University Press; 1954 p. 157-75.
22. Lancefield RC. Persistence of type-specific antibodies in man following infection with group A streptococci. J Exp Med 1959; 110 : 271-92.
23. Griffith F. The serological classification of Streptococcus pyogenes. J Hyg (Lond) 1934; 34 : 542-84.
24. Lancefield RC, Dole VP. The properties of T antigens extracted from group A haemolytic streptococci. J Exp Med 1946; 84 : 449-70.
25. Beall B, Facklam R, Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 1996; 34 : 953-8.
26. Martin DR. Laboratory evaluation of streptococci. In: Stevens DL, Kaplan EL, editors. Streptococcal infections. Clinical aspects, microbiology, and molecular pathogenesis. New York: Oxford University Press; 2000 p. 266-79.
27. Musser JM, Krause RM. The revival of group A streptococcal diseases, with a commentary on staphylococcal toxic shock syndrome. In: Krause RM, editor. Emerging infections. Biomedical research reports. New York: Academic Press; 1998 p. 185-218.
28. Cleary PP, Pritchard KH, McShan WM, Ferretti JJ. Group A streptococcal genetics and virulence. In: Stevens DL, Kaplan EL, editors. Streptococcal infections. Clinical aspects, microbiology, and molecular pathogenesis. New York: Oxford University Press; 2000 p. 37-56.
29. Low DE, Schwartz B, McGeer A. The reemergence of severe group A streptococcal disease: an evolutionary perspective. In: Scheld WM, Armstrong D, Hughes JM, editors. Emerging infections 1. Washington, D.C.: ASM Press; 1998 p. 93-123.
30. Ferretti JJ, McShan WM, Ajdic D, Savic DJ, Savic G, Lyon K, et al. Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc Natl Acad Sci USA 2001; 98 : 4658-63.
31. Smoot JC, Barbian KD, Van Gompel JJ, Smoot LM, Chaussee MS, Sylva GL, et al. Genome sequence and comparative microarray analysis of serotype M18 group A streptococcus strains associated with acute rheumatic fever outbreaks. Proc Natl Acad Sci USA 2002; 99 : 4668-73.
32. Beres SB, Sylva GL, Barbian KD, Lei B, Hoff JS, Mammarella ND, et al. Genome sequence of a serotype M3 strain of group A streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc Natl Acad Sci USA. In press.
33. Schwentker FF, Janney JH, Gordon JE. Epidemiology of scarlet fever. Am J Hyg 1943; 38 : 27-98.
34. Massell BF. Rheumatic fever and streptococcal infection. Unraveling the mysteries of a dread disease. Boston: The Francis A. Countway Library of Medicine. Distributed by the Harvard University Press; 1997.
35. English PC. Rheumatic fever in America and Britain. A biological, epidemiological, and medical history. New Brunswick NJ: Rutgers University Press; 1999.
36. Bland EF, Jones TD. Rheumatic fever and rheumatic heart disease. A twenty-year report on 1,000 patients followed since childhood. Circulation 1951; 4 : 836-43.
37. Jones TD, Bland EF. The natural history of rheumatic fever. In: Thomas L, editor. Rheumatic fever. Minneapolis: University of Minnesota Press; 1952 p. 5-16.
38. Bland EF. Declining severity of rheumatic fever. A comparative study of the past four decades. N Engl J Med 1960; 262 : 597-99.
39. Todd EW. The differentiation of two distinct serological varieties of streptolysin, streptolysin O and streptolysin S. J Pathol Bacteriol 1938; 47 : 423-45.
40. Topley WWC, Wilson GS. The principles of bacteriology and immunity. 1st ed. London: Edward Arnold & Company; 1929 p. 958-9.
41. Topley WWC, Wilson GS. The principles of bacteriology and immunity. 2nd ed. London: Edward Arnold & Company; 1936 p. 1167-8.
42. Elliott SD. The crystallization and serological differentiation of a streptococcal proteinase and its precursor. J Exp Med 1950; 92 : 201-18.
43. Kagawa TF, Cooney JC, Baker HM, McSweeney S, Liu M, Gubba S, et al. Crystal structure of the zymogen form of the group A Streptococcus virulence factor SpeB: an integrin-binding cysteine protease. Proc Natl Acad Sci USA 2000; 97: 2235-40.
44. Anderson HC, Kunkel HG, McCarty M. Quantitative antistreptokinase studies in patients infected with group A hemolytic streptococci: a comparison with serum antistreptolysin and gamma globulin levels with special reference to the occurrence of rheumatic fever. J Clin Invest 1948; 27: 425-34.
45. Holm SE, Nordstrand A, Stevens DL, Norgren M. Acute poststreptococcal glomerulonephritis. In: Stevens DL, Kaplan EL, editors. Streptococcal infections. Clinical aspects, microbiology, and molecular pathogenesis. New York: Oxford University Press; 2000 p. 152-62.
46. Rammelkamp CH Jr. Epidemiology of streptococcal infections. Harvey Lect 1957; 51: 113-42.
47. Siegel AC, Johnson EE, Stollerman GH. Controlled studies of streptococcal pharyngitis in a pediatric population. 2. Behaviour of the type-specific immune response. N Engl J Med 1961; 265 : 566-71.
48. Breese BB, Hall CB. Beta hemolytic streptococcal diseases. Boston: Houghton Mifflin; 1978 p. 79-86.
49. Stetson CA, Rammelkamp CH Jr, Krause RM, Kohen RJ, Perry WD. Epidemic acute nephritis: studies on etiology, natural history and prevention. Medicine 1955: 34 : 431-50.
50. Parker MT, Bassett DCJ, Maxted WR, Arneaud JD. Acute glomerulonephritis in Trinidad: serological typing of group A streptococci. J Hyg (Lond) 1968: 66 : 657-75.
51. Wannamaker LW. Differences between streptococcal infections of the throat and of the skin. I. N Engl J Med 1970; 282 : 23-31.
52. Wannamaker LW. Differences between streptococcal infections of the throat and of the skin, Part II. N Engl J Med 1970; 282 : 78-85.
53. Sharma KB, Bhatia SL. Studies on beta haemolytic streptococci isolated in Delhi. Indian J Med Res 1966; 54 : 517-23.
54. Prakash K, Chawda S, Amma BP, Sharma KB. Distribution of groups and types of beta haemolytic streptococci in cases of rheumatic heart disease and apparently healthy school children. Indian J Pathol Bacteriol 1973; 16 : 5-14.
55. Nandi S, Kumar R, Ray P, Vohra H, Ganguly NK. Group A streptococcal sore throat in a periurban population of northern India: a one-year prospective study. Bull World Health Organ 2001; 79 : 528-33.
56. Rotta J, Krause RM, Lancefield RC, Everly W, Lackland H. New approaches for the laboratory recognition of M types of group A streptococci. J Exp Med 1971; 134 : 1298-315.
57. Tai JY, Gotschlich EC, Lancefield RC. Isolation of type-specific polysaccharide antigen from group B type Ib streptococci. J Exp Med 1979; 149 : 58-66.
58. Baker CJ. Group B streptococcal infections. In: Stevens DL, Kaplan EL, editors. Streptococcal infections. Clinical aspects, microbiology, and molecular pathogenesis. New York: Oxford University Press; 2000 p. 222-37.
59. Coons AH, Kaplan MH. Localization of antigens in tissue cells. II. Improvements in a method for the detection of antigen by means of fluorescent antibody. J Exp Med 1950; 91 : 1-13.
60. Coons AH. The penetration of antigens into connective tissue. In: Thomas L, editor. Rheumatic fever. Minneapolis: University of Minnesota Press; 1952 p. 217-23.
61. Ayoub EM, Kotb M, Cunningham MW. Rheumatic fever pathogenesis. In : Stevens DL, Kaplan EL, editors. Streptococcal infections. Clinical aspects, microbiology, and molecular pathogenesis. New York: Oxford University Press; 2000 p. 102-32.
62. Patarroyo ME, Winchester RJ, Vejerano A, Gibofsky A, Chalem F, Zabriskie JB, et al. Association of a B-cell alloantigen with susceptibility to rheumatic fever. Nature 1979; 278 : 173-4.
63. Gibofsky A, Khanna A, Suh E, Zabriskie JB. The genetics of rheumatic fever; relation to streptococcal infection and autoimmune disease. J Rheumatol 1991; 18 (Suppl 30): 1-5.
64. Kumar D, Kaul P, Grover A, Ganguly NK. Distribution of cells bearing B-cell alloantigen(s) in north Indian rheumatic fever/rheumatic heart disease patients. Mol Cell Biochem 2001; 218: 21-6.
65. McCarty M. The streptococcal cell wall. Harvey Lect 1971; 65: 73-96.
66. Krause RM. Symposium on relationship of structure of microorganisms to their immunological properties. IV. Antigenic and biochemical composition of haemolytic streptococcal cell walls. Bacteriol Rev 1963; 27: 369-80.
67. Coligan JE, Kindt TJ, Krause RM. Structure of the streptococcal groups A, A-variant and C carbohydrates. Immunochemistry 1978; 15: 755-60.
68. Freimer EH, Krause RM, McCarty M. Studies of L forms and protoplasts of group A streptococci. I. Isolation, growth, and bacteriologic characteristics. J Exp Med 1959; 110: 853-74.
69. Mundhra BK, Chugh KS, Mohan C, Ganguly NK, Sharma S. Role of L-forms of bacteria in recurrent urinary tract infection. Indian J Med Res 1977; 66: 400-6.
70. Woo PCY, Wong SSY, Lum PNL, Hui WT, Yuen KY. Cell-wall deficient bacteria and culture-negative febrile episodes in bone-marrow transplant recipients. Lancet 2001; 357: 675-9.
71. Baddiley J. Teichoic acids in walls and cells of Gram positive bacteria. Fed Proc 1962; 21: 1084-97.
72. Maxted WR. The influence of bacteriophage on Streptococcus pyogenes. J Gen Microbiol 1955; 12: 484-95.
73. Kjems E. Studies on the streptococcal bacteriophages. I. Technique for isolating phage-producing strains. Acta Pathol Microbiol Scand 1955; 36: 433-40.
74. Krause RM. Studies on bacteriophages of hemolytic streptococci. I. Factors influencing the interaction of phage and susceptible host cell. J Exp Med 1957; 106: 365-83.
75. Zabriskie JB. The role of temperate bacteriophage in the production of erythrogenic toxin by group A streptococci. J Exp Med 1964; 119: 761-80.
76. Hollingshead SK, Fischetti VA, Scott JR. Complete nucleotide sequence of type 6 M protein of the group A streptococcus. Repetitive structure and membrane anchor. J Biol Chem 1986; 261: 1677-86.
77. Swanson J, Hsu KC, Gotschlich EC. Electron microscopic studies on streptococci. I. M antigen. J Exp Med 1969; 130: 1063-91.
78. Kleinschmidt AK. Nucleinsäuren. Architektur und wandlungsfähigkeit im molekularen bild [Nucleic acids. Architecture and flexibility in the molecular picture]. Naturwissenschaften 1967; 54: 417-28.
79. Eichmann K, Kindt TJ. The inheritance of individual antigenic specificities of rabbit antibodies to streptococcal carbohydrates. J Exp Med 1971; 134: 532-52.
80. Massell BF. A possible vaccine for prevention of streptococcal infections. Chap. 14. In: Rheumatic fever and streptococcal infection. Unraveling the mysteries of a dread disease. Boston: The Francis A. Countway Library of Medicine. Distributed by the Harvard University Press; 1997 p. 240-64.
81. Fox EN, Waldman RH, Wittner MK, Mauceri AA, Dorfman A. Protective study with a group A streptococcal M protein vaccine. Infectivity challenge of human volunteers. J Clin Invest 1973; 52: 1885-92.
82. Fischetti VA. Protection against group A streptococcal infection. In: Stevens DL, Kaplan EL, editors. Streptococcal infections. Clinical aspects, microbiology, and molecular pathogenesis. New York: Oxford University Press; 2000 p. 371-89.
83. Dale JB. Multivalent group A streptococcal vaccines. In: Stevens DL, Kaplan EL, editors. Streptococcal infections. Clinical aspects, microbiology, and molecular pathogenesis. New York: Oxford University Press; 2000 p. 390-401.